17 février 2010
Tanezumab, a recombinant humanized mAb against nerve growth factor for the treatment of acute and chronic pain.
Tanezumab, a recombinant humanized mAb against nerve growth factor for the treatment of acute and chronic pain.
/https%3A%2F%2Fassets.over-blog.com%2Ft%2Fcedistic%2Fcamera.png)
Publicité
Commentaires